Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Truffot-Pernot

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1993
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in miceV Lalande, C Truffot-Pernot, A Paccaly-Moulin, et al.
Lancet (London, England)|February 27, 1988
Tuberculous meningitis due to BCG in two previously healthy childrenM Tardieu, C Truffot-Pernot, J P Carriere, et al.
Acta Leprologica|January 1, 1982
[Comparative bactericidal action of rifampicin alone on M. tuberculosis and M. leprae]C C Guelpa-Lauras, J Grosset, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosisB Ji, N Lounis, C Maslo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Tuberculosis caused by Mycobacterium africanum associated with involvement of the upper and lower respiratory tract, skin, and mucosaL Baril, E Caumes, C Truffot-Pernot, et al.
The Journal of Infectious Diseases|November 1, 1994
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacinE Cambau, W Sougakoff, M Besson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 23, 2000
Twenty-five years of tuberculosis in a French university hospital: a laboratory perspectiveJ Robert, D Trystram, C Truffot-Pernot, et al.
The European Respiratory Journal|June 15, 2007
A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995-2004P M Khuê, C Truffot-Pernot, J Texier-Maugein, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 24, 2001
Mycobacterial growth indicator tube versus the proportion method on Löwenstein-Jensen medium for antibiotic susceptibility testing of Mycobacterium tuberculosisE Cambau, C Truffot-Pernot, F Boulahbal, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of clarithromycin regimens against Mycobacterium xenopi in miceN Lounis, C Truffot-Pernot, A Bentoucha, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|March 1, 1993
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in miceV Lalande, C Truffot-Pernot, A Paccaly-Moulin, et al.
Lancet (London, England)|February 27, 1988
Tuberculous meningitis due to BCG in two previously healthy childrenM Tardieu, C Truffot-Pernot, J P Carriere, et al.
Acta Leprologica|January 1, 1982
[Comparative bactericidal action of rifampicin alone on M. tuberculosis and M. leprae]C C Guelpa-Lauras, J Grosset, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosisB Ji, N Lounis, C Maslo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Tuberculosis caused by Mycobacterium africanum associated with involvement of the upper and lower respiratory tract, skin, and mucosaL Baril, E Caumes, C Truffot-Pernot, et al.
The Journal of Infectious Diseases|November 1, 1994
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacinE Cambau, W Sougakoff, M Besson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 23, 2000
Twenty-five years of tuberculosis in a French university hospital: a laboratory perspectiveJ Robert, D Trystram, C Truffot-Pernot, et al.
The European Respiratory Journal|June 15, 2007
A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995-2004P M Khuê, C Truffot-Pernot, J Texier-Maugein, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 24, 2001
Mycobacterial growth indicator tube versus the proportion method on Löwenstein-Jensen medium for antibiotic susceptibility testing of Mycobacterium tuberculosisE Cambau, C Truffot-Pernot, F Boulahbal, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of clarithromycin regimens against Mycobacterium xenopi in miceN Lounis, C Truffot-Pernot, A Bentoucha, et al.
Pageof 8